Sidra Medicine, a member of Qatar Foundation, has been awarded 11 grants valued at approximately QR10.4mn from the Qatar National Research Fund (QNRF).
The grants will support both Sidra Medicine’s as well as Qatar’s national precision medicine programme; enabling personalised clinical care for patients in Qatar and beyond.
Commenting on the grants, Dr Khalid Fakhro, acting chief research officer, Sidra Medicine said: “Over the past four years, Sidra Medicine’s research department has been awarded over 35 grants from the Qatar National Research Fund.


Dr Khalid Fakhro

"This is testament to the foundational role Sidra Medicine is playing in expanding Qatar’s research capacity and knowledge base. Many of our grants are tied to addressing a real clinical or research challenges that can positively impact patient outcomes.”
The grants are under four QNRF streams: the National Priorities Research Programme Cycle 12; Path Towards Precision Medicine Cycle 3; Conference and Workshop Sponsorship Program Cycle 17 and the Researchers Exchange and Mobility Programme.
Key projects awarded include biomedical and health programmes that will allow clinicians to select suitable treatments for specific infectious diseases; how stem cells can be used as a therapeutic tool for type 1 diabetes as well as a precision medicine approach to prevent diabetic complications in affected Qatari individuals. Grants were also awarded to projects that will map the genetic causes of infertility and genome editing for cell-based cancer immunotherapy. More information about Sidra Medicine’s research agenda can be accessed at www.sidra.org/research.